Replies to post #6501 on Vericel Corp. (VCEL)

[lasers]

Vericel to Present at the Ladenburg Thalmann 2017 Healthcare Conference
GLOBENEWSWIRE 8:00 AM ET 9/20/2017
Symbol Last Price Change
VCEL 4.85up 0 (0%)
QUOTES AS OF 04:00:00 PM ET 09/19/2017
CAMBRIDGE, Mass., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation(VCEL) , a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the Ladenburg Thalmann 2017 Healthcare Conference at the Sofitel Hotel in New York City on Tuesday, Sept. 26, 2017, at 3:00 p.m. EDT.


The presentation will be webcast live at http://wsw.com/webcast/ladenburg3/vcel and may be accessed from the news and events section of the Vericel(VCEL) website.

About Vericel Corporation(VCEL)
Vericel (VCEL) develops, manufactures, and markets expanded autologous cell therapies for the treatment of patients with serious diseases and conditions. The company markets two cell therapy products in the United States. Vericel(VCEL) is marketing MACI® (autologous cultured chondrocytes on porcine collagen membrane), an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Vericel(VCEL) is also marketing Epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. Vericel(VCEL) is developing ixmyelocel-T, an autologous multicellular therapy intended to treat advanced heart failure due to ischemic dilated cardiomyopathy. For more information, please visit the company's website at www.vcel.com.

Epicel® and MACI® are registered trademarks of Vericel Corporation(VCEL). © 2017 Vericel Corporation(VCEL). All rights reserved.

Global Media Contacts:
David Schull
Russo Partners LLC
[phone] (office)
[phone] (mobile)
[e-mail]

Karen Chase
Russo Partners LLC
[phone] (office)
[phone] (mobile)
[e-mail]

Investor Contacts:
Chad Rubin
The Trout Group
[e-mail]
[phone]

Lee Stern
The Trout Group
[e-mail]
[phone]

Image: Primary Logo


Source: Vericel Corporation(VCEL)
2017 GlobeNewswire, Inc.

[aidenb8]

You're welcome Hurley :) It's always good to have someone that reminds of the strategy and provides vision, and remind everyone of the roadmap.

I felt everyone; shareholders and Vericel Execs need to be reminded this bright future, and don't get distracted with day to day operation, and tactics.

It's like you are swimming across the ocean, and you are tired, and want to give up, and hang on everything. Someone just needs to tell you that there is only 2 miles left to reach the destination, since you can't see the coast in the water.

That someone should be there to only remind you of your original goal, and why you have come this long; also remind you of the muscles you have.

I will not sell a single share of $VCEL under $40.